Showing 10,721 - 10,740 results of 11,009 for search 'limitation program', query time: 0.17s Refine Results
  1. 10721

    Serotonin receptor 5-HT2A as a potential target for HCC immunotherapy by Han Chong Toh, Olaf Rotzschke, Yi Wen Tan, Nicholas Da Zhi Ang, Wendy Lee, Ser Mei Koh, Rong En Tay, Charmaine Min Ho, Hui Chien Tay, Daniel Z Lopez, Qiao Rui Na, Kim Peng Tan, Jackwee Lim, Maichan Lau, Laurent Rénia

    Published 2025-06-01
    “…In vivo, systemic ketanserin treatment significantly prolonged survival of HCC tumor-bearing mice and was non-inferior to α-programmed death ligand 1 (PD-L1)+α-vascular endothelial growth factor A (VEGFA) combination antibody treatment. …”
    Get full text
    Article
  2. 10722

    Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer by Al B Benson, Anirban Maitra, Milind Javle, Michael Overman, Richard E Davis, Pankaj Vats, Chandan Kumar-Sinha, Lianchun Xiao, Niharika B Mettu, Edwin R Parra, Charles D Lopez, Veerendra Munugalavadla, Priti Patel, Lin Tao, Sattva Neelapu

    Published 2020-05-01
    “…Preclinical studies in pancreatic cancer have demonstrated promising anti-tumor activity with Bruton tyrosine kinase (BTK) inhibition combined with programmed cell death receptor-1 (PD-1) blockade.Methods This was a phase II, multicenter, open-label, randomized (1:1) clinical trial evaluating the BTK inhibitor acalabrutinib, alone (monotherapy) or in combination with the anti-PD-1 antibody pembrolizumab (combination therapy). …”
    Get full text
    Article
  3. 10723
  4. 10724
  5. 10725

    Non-consistent changes and drivers of water-sediment fluxes in the yarlung tsangpo river basin of the Tibetan plateau by Dongmei Zhao, Donghong Xiong, Kunlong He, Baojun Zhang, Fan Zhang, Han Wu, Haiyan Fang, Wenduo Zhang, Changyan Zhou, Xiaodan Wang

    Published 2025-06-01
    “…Yet, current estimates of the response of water and sediment flux remain insufficiently quantified, limited by the scarcity of long-term hydrological records in the alpine regions. …”
    Get full text
    Article
  6. 10726
  7. 10727
  8. 10728
  9. 10729

    Mitochondrial genome of Lonicera macranthoides: features, RNA editing, and insights into male sterility by Zhong Chen, Wei Zhuo, Yuqi Wang, Junpeng Qi, Li Liu, Sheng’E. Lu, Han Wang, Tao Sun, Liqiang Wang, Fengming Ren, Fengming Ren

    Published 2025-01-01
    “…Overall, our study provides a complete mitogenome of L. macranthoides, which will aid in its genetic marker exploration, evolutionary relationship analysis, and breeding programs.…”
    Get full text
    Article
  10. 10730

    Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosisResearch in context by Giovanna Carpi, Marva Seifert, Andres De la Rossa, Swapna Uplekar, Camilla Rodrigues, Nestani Tukvadze, Shaheed V. Omar, Anita Suresh, Timothy C. Rodwell, Rebecca E. Colman

    Published 2025-09-01
    “…These findings provide critical evidence to guide updates in DR-TB diagnostic programs. Funding: Support for the Seq&Treat project was provided through funding from Unitaid (2019-32-FIND MDR).…”
    Get full text
    Article
  11. 10731

    Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multi... by Ke Zhang, Qifeng Wang, Jianzhong Cao, Chengcheng Fan, Wenbin Shen, Qin Xiao, Xiaolin Ge, Tian Zhang, Xiao Liu, Xi Chen, Jie Dong, Zewei Li, Zhunhao Zheng, Cihui Yan, Ping Wang, Qingsong Pang, Wencheng Zhang

    Published 2025-02-01
    “…However, the 3-year overall survival (OS) is limited to approximately 40%. Tislelizumab is the first- and second-line standard treatment for advanced ESCC with tolerable toxicity. …”
    Get full text
    Article
  12. 10732

    Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice by Markus Wöhr, Wendy M. Fong, Justyna A. Janas, Moritz Mall, Christian Thome, Madhuri Vangipuram, Lingjun Meng, Thomas C. Südhof, Marius Wernig

    Published 2022-05-01
    “…Molecularly, we found it to repress many non-neuronal gene programs, explaining its supportive role to induce and safeguard neuronal identity in combination with proneural bHLH transcriptional activators. …”
    Get full text
    Article
  13. 10733
  14. 10734
  15. 10735

    Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial by Linda Mileshkin, Elizabeth Barnes, Tarek Meniawy, Kristy Robledo, Michael Friedlander, Geraldine Goss, Jermaine Coward, Yoland Antill, Michelle Cummins, Sally Baron-Hay, Martin R Stockler, Catherine Shannon, Philip Beale, Peey-Sei Kok, Deborah Smith, Sonia Yip, Amanda Spurdle, Yeh Chen Lee, Janine Lombard, John Andrews

    Published 2021-06-01
    “…Background In this study, we assessed the activity of durvalumab, an antibody to programmed death ligand-1, in two cohorts of women with advanced endometrial cancers (AEC)—mismatch repair proficient (pMMR) and mismatch repair deficient (dMMR).Methods A multicenter phase two study was performed in women with AEC with pMMR tumor progressing after one to three lines of chemotherapy and women with AEC with dMMR tumor progressing after zero to three lines of chemotherapy. …”
    Get full text
    Article
  16. 10736

    Smartphone addiction and sleep quality among nursing students in Meknes, Morocco: A cross-sectional study by Abdelhadi El Haddaouy, Youssef Miyah, Mohammed Benjelloun, Aziz Mengad, Hicham Blaak, Hayat Iziki, Fatima El Omari

    Published 2025-04-01
    “…However, research on this subject in Morocco remains limited. Objective: This study aimed to examine the impact of smartphone addiction on sleep quality and identify risk factors that moderate this relationship among nursing students. …”
    Get full text
    Article
  17. 10737

    Study on the efficacy of IFN-γ- and sPD-1-overexpressing BMSCs in enhancing immune effects for the treatment of lung adenocarcinoma by Yahui Xie, Zhen Lv, Yubin Wang, Jin Ma, Xingmin Wei, Guisen Zheng, Jianjun Wu

    Published 2025-03-01
    “…BackgroundSoluble programmed cell death receptor-1 (sPD-1) blocks the PD-1/PD-L1 pathway, reverses tumor immune suppression, and inhibits tumor growth. …”
    Get full text
    Article
  18. 10738

    Systematic review and meta-analysis of effectiveness of robotic therapy in the recovery of motor functions after stroke by Mariyam Amirbekova, Tokzhan Kispayeva, Tokzhan Kispayeva, Ausra Adomaviciene, Laura Eszhanova, Inna Bolshakova, Zhanna Ospanova

    Published 2025-07-01
    “…The findings support early stratification and personalization of rehabilitation programs based on stroke timing, age, and intervention intensity. …”
    Get full text
    Article
  19. 10739

    Healthcare workers’ knowledge, attitudes, and practices on catheter-associated UTI prevention: influencing factors in an OB/GYN hospital by Fei Qu, Yanyu Pang, Mei Wang, Xiaojie Liu, Jing Wang, Jing Wang, Li Li

    Published 2025-02-01
    “…The ultimate aim is to provide evidence for improving targeted training programs and infection control measures.Methods and participantsA cross-sectional study was conducted in an OB/GYN hospital in Shanghai, China. …”
    Get full text
    Article
  20. 10740

    Physician burnout, associated factors, and their effects on work performance throughout first-year internships during the COVID-19 pandemic in Thailand: a cross-sectional study by Vithawat Surawattanasakul, Penprapa Siviroj, Wuttipat Kiratipaisarl, Wachiranun Sirikul, Vitchayut Phetsayanavin, Chantarateera Pholvivat, Natcha Auernaruemonsuk, Chanon Lamlert

    Published 2025-05-01
    “…To address these issues, mentorship programs and buddy support systems, along with adherence to recommended work-hour guidelines, are crucial to mitigate burnout and improve work performance.…”
    Get full text
    Article